Complete Inhibition of Rhabdomyosarcoma Xenograft Growth and Neovascularization Requires Blockade of Both Tumor and Host Vascular Endothelial Growth Factor

Hans-Peter Gerber; Joe Kowalski; Daniel Sherman; David A. Eberhard; Napoleone Ferrara

Advances in Brief

Complete Inhibition of Rhabdomyosarcoma Xenograft Growth and Neovascularization Requires Blockade of Both Tumor and Host Vascular Endothelial Growth Factor

Hans-Peter Gerber, Joe Kowalski, Daniel Sherman, David A. Eberhard and Napoleone Ferrara

Hans-Peter Gerber

Departments of Molecular Oncology [H-P. G., J. K., D. S., N. F.] and Pathology [D. A. E.], Genentech Incorporated, South San Francisco, California 94080

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joe Kowalski

Departments of Molecular Oncology [H-P. G., J. K., D. S., N. F.] and Pathology [D. A. E.], Genentech Incorporated, South San Francisco, California 94080

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Sherman

Departments of Molecular Oncology [H-P. G., J. K., D. S., N. F.] and Pathology [D. A. E.], Genentech Incorporated, South San Francisco, California 94080

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David A. Eberhard

Departments of Molecular Oncology [H-P. G., J. K., D. S., N. F.] and Pathology [D. A. E.], Genentech Incorporated, South San Francisco, California 94080

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Napoleone Ferrara

Departments of Molecular Oncology [H-P. G., J. K., D. S., N. F.] and Pathology [D. A. E.], Genentech Incorporated, South San Francisco, California 94080

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: Published November 2000

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2001 to February 2021

	Abstract	Full-text HTML	PDF
Total	2340	6521	4416

Cited By

Article Information

Volume 60, Issue 22, pp. 6253-6258

PubMed

11103779

Published By

American Association for Cancer Research

Print ISSN

0008-5472

Online ISSN

1538-7445

History

Received June 5, 2000
Accepted October 5, 2000
Published first November 1, 2000.

Author Information

Hans-Peter Gerber,
Joe Kowalski,
Daniel Sherman,
David A. Eberhard, and
Napoleone Ferrara1

Departments of Molecular Oncology [H-P. G., J. K., D. S., N. F.] and Pathology [D. A. E.], Genentech Incorporated, South San Francisco, California 94080

View Full Text

PreviousNext

November 2000
Volume 60, Issue 22

Table of Contents

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Complete Inhibition of Rhabdomyosarcoma Xenograft Growth and Neovascularization Requires Blockade of Both Tumor and Host Vascular Endothelial Growth Factor

Message Subject (Your Name) has forwarded a page to you from Cancer Research

Message Body (Your Name) thought you would be interested in this article in Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Complete Inhibition of Rhabdomyosarcoma Xenograft Growth and Neovascularization Requires Blockade of Both Tumor and Host Vascular Endothelial Growth Factor

Hans-Peter Gerber, Joe Kowalski, Daniel Sherman, David A. Eberhard and Napoleone Ferrara

Cancer Res November 15 2000 (60) (22) 6253-6258;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Complete Inhibition of Rhabdomyosarcoma Xenograft Growth and Neovascularization Requires Blockade of Both Tumor and Host Vascular Endothelial Growth Factor